Skip to main content

Table 1 Baseline Demographic and Clinical Data

From: Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases

 

all cases

with renal biopsy

without renal biopsy

P value

no. of case

102

43

59

 

sex (M:F)

46: 56

17: 26

29: 30

p = 0.4b

age (years)

55.07 ± 14.99

55.43 ± 14.87

54.81 ± 15.19

p = 0.8a

blood pressure (mmHg)

    

 systolic

151.3 ± 47.0

144.0 ± 19.2

156.7 ± 59.2

p = 0.2a

 diastolic

78.5 ± 13.4

77.7 ± 12.7

79.2 ± 13.9

p = 0.6a

serum creatinine (μmol/l)

203.50 (98.25–387.75)

127.00 (69.50–283.00)

242.00 (116.00–473.50)

p = 0.011c

estimated GFR (ml/min/1.73m2)

44.27 ± 42.63

53.49 ± 39.90

37.55 ± 43.62

p = 0.06a

proteinuria (g/day)

1.11 (0.33–2.44)

1.21 (0.61–2.32)

1.03 (0.28–2.45)

p = 0.6c

urinary mtDNA

1519.42 (511.81–3073.03)

1825.33 (753.63–6749.94)

1207.37 (499.45–2319.48)

p = 0.047c

  1. GFR glomerular filtration rate, mtDNA mitochondrial DNA (expressed as million copy per mmol creatinine in urine)
  2. Data are expressed as mean ± standard deviation or median (inter-quartile range [IQR]), and compared by aStudent’s t test, bChi-square test, or cMann-Whitney U test